亨德拉病毒
病毒学
爆发
疾病
蓝图
执照
非人灵长类
生物
医学
埃博拉病毒
进化生物学
机械工程
工程类
病理
护理部
作者
Chad E. Mire,Benjamin A. Satterfield,Thomas W. Geisbert
出处
期刊:Methods in molecular biology
日期:2023-01-01
卷期号:: 159-173
标识
DOI:10.1007/978-1-0716-3283-3_12
摘要
Hendra and Nipah viruses are henipaviruses that have caused lethal human disease in Australia and Malaysia, Bangladesh, India, and the Philippines, respectively. These viruses are considered Category C pathogens by the US Centers for Disease Control. Nipah virus was recently placed on the World Health Organization Research and Development Blueprint Roadmaps for vaccine and therapeutic development. Given the infrequent and unpredictable nature of henipavirus outbreaks licensure of vaccines and therapeutics will likely require an animal model to demonstrate protective efficacy against henipavirus disease. Studies have shown that nonhuman primates are the most accurate model of human henipavirus disease and would be an important component of any application for licensure of a vaccine or antiviral drug under the US FDA Animal Rule. Nonhuman primate model selection and dosing are discussed regarding vaccine and therapeutic studies against henipaviruses.
科研通智能强力驱动
Strongly Powered by AbleSci AI